Research Article

Mitochondrial DNA Content Varies with Pathological Characteristics of Breast Cancer

Table 1

Correlation of mtDNA content in breast cancer with clinicopathological features.

mtDNA content in tumor tissueT/N ratio of mtDNA content
nMean ± SDP value*Mean ± SDP value*

Age (years)

<4056592 ± 5300.861 ± 0.561
40–49103588 ± 4730.6030.967 ± 0.70.817
50–5977 0.956 ± 0.92
≥6057577 ± 4020.956 ± 0.849

Tumor size (cm3)(versus C)(versus C)

A: ≤4.979735 ± 412 1.088 ± 0.636
B: 5~14.966574 ± 354 1.000 ± 0.556
C: 15–49.975372 ± 2480.696 ± 0.459
D: ≥5053535 ± 3850.3060.818 ± 0.5530.258

Grade

0~I18669 ± 4120.995 ± 0.681
II125506 ± 3180.019 (versus 0~I)0.791 ± 0.5310.827 (versus 0~I)
III98648 ± 4320.383 (versus 0~I)
0.006 (versus II)
1.128 ± 0.9880.441 (versus 0~I)
0.033 (versus II)

ER

Negative107502 ± 4050.1030.810 ± 0.6120.047
Positive157573 ± 3741.057 ± 1.059

PR

Negative100494 ± 3520.0610.839 ± 0.6330.059
Positive154597 ± 3841.034 ± 0.772

ER/PR

A:ER,PR both − or either +134473 ± 3160.0050.837 ± 0.5360.355
B: ER+/PR+129618 ± 3810.930 ± 0.617

Her2/neu receptor

Negative56444 ± 3330.1010.727 ± 0.5180.023
Positive168531 ± 3461.127 ± 1.184

values are from Mann-Whitney or Kruskal-Wallis test. The values <0.05 are in bold, indicating significance; the values >0.05, but <0.15 are in italic, indicating weak significance.